Your browser doesn't support javascript.
loading
OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantation.
Holtick, Udo; Chemnitz, Jens-Markus; Shimabukuro-Vornhagen, Alexander; Theurich, Sebastian; Chakupurakal, Geothy; Krause, Anke; Fiedler, Anne; Luznik, Leo; Hellmich, Martin; Wolf, Dominik; Hallek, Michael; von Bergwelt-Baildon, Michael; Scheid, Christof.
Afiliação
  • Holtick U; Stem Cell Transplantation Program, Department I of Internal Medicine, Center for Integrated Oncology CIO KölnBonn, University Hospital of Cologne, Cologne, Germany.
  • Chemnitz JM; Cologne Interventional Immunology, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
  • Shimabukuro-Vornhagen A; Stem Cell Transplantation Program, Department I of Internal Medicine, Center for Integrated Oncology CIO KölnBonn, University Hospital of Cologne, Cologne, Germany.
  • Theurich S; Stem Cell Transplantation Program, Department I of Internal Medicine, Center for Integrated Oncology CIO KölnBonn, University Hospital of Cologne, Cologne, Germany.
  • Chakupurakal G; Cologne Interventional Immunology, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
  • Krause A; Stem Cell Transplantation Program, Department I of Internal Medicine, Center for Integrated Oncology CIO KölnBonn, University Hospital of Cologne, Cologne, Germany.
  • Fiedler A; Cologne Interventional Immunology, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
  • Luznik L; Stem Cell Transplantation Program, Department I of Internal Medicine, Center for Integrated Oncology CIO KölnBonn, University Hospital of Cologne, Cologne, Germany.
  • Hellmich M; Cologne Interventional Immunology, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
  • Wolf D; Stem Cell Transplantation Program, Department I of Internal Medicine, Center for Integrated Oncology CIO KölnBonn, University Hospital of Cologne, Cologne, Germany.
  • Hallek M; Cologne Interventional Immunology, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
  • von Bergwelt-Baildon M; Sidney Kimmel Comprehensive Cancer Center and Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Scheid C; Institute of Medical Statistics, Informatics and Epidemiology, University of Cologne, Cologne, Germany.
Eur J Haematol ; 96(1): 27-35, 2016 Jan.
Article em En | MEDLINE | ID: mdl-25703164
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Ciclofosfamida / Transplante de Células-Tronco de Sangue Periférico / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Ciclofosfamida / Transplante de Células-Tronco de Sangue Periférico / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido